{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:33:52Z","timestamp":1707525232300},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,16]]},"DOI":"10.7759\/cureus.45336","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T08:09:50Z","timestamp":1694851790000},"source":"Crossref","is-referenced-by-count":0,"title":["Limited Cutaneous Scleroderma: A Case Report"],"prefix":"10.7759","author":[{"given":"Manvi","family":"Marathe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Borkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"7","author":"Denton CP","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017, 7:1685-99. 10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20152890","article-title":"Localized scleroderma: clinical spectrum and therapeutic update","volume":"90","author":"Careta MF","year":"2015","unstructured":"Careta MF, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015, 90:62-73. 10.1590\/abd1806-4841.20152890","journal-title":"An Bras Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.24875\/GMM.M20000336","article-title":"Morphea: a practical review of its diagnosis, classification and treatment","volume":"155","author":"Rodr\u00edguez-Salgado P","year":"2019","unstructured":"Rodr\u00edguez-Salgado P, Garc\u00eda-Romero MT. Morphea: a practical review of its diagnosis, classification and treatment. Gac Med Mex. 2019, 155:483-91. 10.24875\/GMM.M20000336","journal-title":"Gac Med Mex"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8192-4","article-title":"The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies","volume":"40","author":"Weckerle CE","year":"2011","unstructured":"Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011, 40:42-9. 10.1007\/s12016-009-8192-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-857x(03)00023-1","article-title":"Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being","volume":"29","author":"Medsger TA","year":"2003","unstructured":"Medsger TA. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003, 29:255-73. 10.1016\/s0889-857x(03)00023-1","journal-title":"Rheum Dis Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/sder.2001.23093","article-title":"Localized and systemic scleroderma","volume":"20","author":"Hawk A","year":"2001","unstructured":"Hawk A, English JC 3rd. Localized and systemic scleroderma. Semin Cutan Med Surg. 2001, 20:27-37. 10.1053\/sder.2001.23093","journal-title":"Semin Cutan Med Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.24875\/GMM.18004288","article-title":"Morphea: practical review of its diagnosis, classification and treatment [Article in Spanish]","volume":"155","author":"Rodr\u00edguez-Salgado P","year":"2019","unstructured":"Rodr\u00edguez-Salgado P, Garc\u00eda-Romero MT. Morphea: practical review of its diagnosis, classification and treatment [Article in Spanish]. Gac Med Mex. 2019, 155:522-31. 10.24875\/GMM.18004288","journal-title":"Gac Med Mex"},{"key":"ref8","article-title":"Juvenile scleroderma [Article in Portuguese]","volume":"33","author":"de M\u00e2cedo PA","year":"2008","unstructured":"de M\u00e2cedo PA, Shinjo SK, Goldenstein-Schainberg C. Juvenile scleroderma [Article in Portuguese]. Acta Reumatol Port. 2008, 33:289-97.","journal-title":"Acta Reumatol Port"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2018.02.004","article-title":"Scleroderma in children","volume":"31","author":"Zulian F","year":"2017","unstructured":"Zulian F. Scleroderma in children. Best Pract Res Clin Rheumatol. 2017, 31:576-95. 10.1016\/j.berh.2018.02.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15811","article-title":"Localized scleroderma: actual insights and new biomarkers","volume":"61","author":"Snarskaya ES","year":"2022","unstructured":"Snarskaya ES, Vasileva KD. Localized scleroderma: actual insights and new biomarkers. Int J Dermatol. 2022, 61:667-74. 10.1111\/ijd.15811","journal-title":"Int J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1993.tb00719.x","article-title":"Scleroderma - clinical aspects","volume":"234","author":"Black CM","year":"1993","unstructured":"Black CM. Scleroderma - clinical aspects. J Intern Med. 1993, 234:115-18. 10.1111\/j.1365-2796.1993.tb00719.x","journal-title":"J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3155","article-title":"Clinical profile of methotrexate-resistant juvenile localised scleroderma","volume":"99","author":"Hardy J","year":"2019","unstructured":"Hardy J, Boralevi F, Mallet S, et al.. Clinical profile of methotrexate-resistant juvenile localised scleroderma. Acta Derm Venereol. 2019, 99:539-43. 10.2340\/00015555-3155","journal-title":"Acta Derm Venereol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0031-3955(16)36111-9","article-title":"scleroderma in childhood","volume":"33","author":"Singsen BH","year":"1986","unstructured":"Singsen BH. scleroderma in childhood. Pediatr Clin North Am. 1986, 33:1119-39. 10.1016\/s0031-3955(16)36111-9","journal-title":"Pediatr Clin North Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2012.01479.x","article-title":"Localized scleroderma","volume":"25","author":"Kreuter A","year":"2012","unstructured":"Kreuter A. Localized scleroderma. Dermatol Ther. 2012, 25:135-47. 10.1111\/j.1529-8019.2012.01479.x","journal-title":"Dermatol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5079","article-title":"Morphea (localized scleroderma)","volume":"149","author":"Fett NM","year":"2013","unstructured":"Fett NM. Morphea (localized scleroderma). JAMA Dermatol. 2013, 149:1124. 10.1001\/jamadermatol.2013.5079","journal-title":"JAMA Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161900-limited-cutaneous-scleroderma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:06Z","timestamp":1707509106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161900-limited-cutaneous-scleroderma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.45336","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,16]]}}}